Recombinant parathyroid hormone (1-34) - Uni-Bio Science Group

Drug Profile

Recombinant parathyroid hormone (1-34) - Uni-Bio Science Group

Alternative Names: Recombinant parathyroid hormone (1-34); Uni PH (1-34); Uni rPH (1-34); Uni-PTH

Latest Information Update: 08 Jun 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Uni-Bio Science Group
  • Class Osteoporosis therapies; Peptide hormones; Skin disorder therapies
  • Mechanism of Action Osteogenesis stimulants; Parathyroid hormone receptor type 1 agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preregistration Postmenopausal osteoporosis

Most Recent Events

  • 05 Jun 2018 Uni-Bio Science plans to launch Recombinant parathyroid hormone
  • 08 Apr 2015 Preregistration for Postmenopausal osteoporosis in China (SC)
  • 21 Oct 2013 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top